Bromocriptine in Parkinson's disease: report on 106 patients treated for up to 5 years
Lieberman, A.N.; Kupersmith, M.; Neophytides, A.; Gopinathan, G.; Casson, I.; Durso, R.; Foo, S.H.; Khayali, M.; Tartaro, T.; Goldstein, M.
Advances in Biochemical Psychopharmacology 23: 245-253
1980
ISSN/ISBN: 0065-2229 PMID: 7395614 Document Number: 161594
Document emailed within 1 workday
Related Documents
De Quintana-Schmidt, C.; Pascual-Sedano, B.; Alvarez-Holzapfel, M.J.ús.; Gironell, A.; Leidinger, A.; Benito, N.; Rodríguez-Rodríguez, R.; Molet-Teixidó, J. 2014: Complications related with implanted devices in patients with Parkinson's disease treated with deep brain stimulation. a study of a series of 124 patients over a period of 16 years Revista de Neurologia 59(2): 49-56Indo, T.; Takahashi, A. 1987: Should L-dopa therapy for Parkinson's disease be started early or late? Clinical course of the major tetrad in 122 Parkinsonian patients treated with L-dopa over 14 years Rinsho Shinkeigaku 27(11): 1419-1422
Mackenzie, R.A.; Lance, J.W. 1978: An evaluation of bromocriptine in the treatment of Parkinson's disease Clinical and Experimental Neurology 15: 228-236
Seibel, M.M.; Oskowitz, S.; Kamrava, M.; Taymor, M.L. 1984: Bromocriptine response in normoprolactinemic patients with polycystic ovary disease: a preliminary report Obstetrics and Gynecology 64(2): 213-219
Liaño, H.; López-Lozano, J.J.; Ramírez, A.; Rabes, C.; Pascual, M.L. 1984: Use of bromocriptine in Parkinson diseases in low doses at a slow rate. 40 patients Archivos de Neurobiologia 47(3): 143-150
Maes, H.; Vingerhoets, F.; Berney, A. 2011: Prevalence of mood disorders in Parkinson's disease patients treated with subthalamic nucleus deep brain stimulation Revue Medicale Suisse 7(282): 385-388
Tanasanvimon, S.; Ayuthaya, N.I.N.; Phanthumchinda, K. 2007: Modified Parkinson's Disease Sleep Scale (MPDSS) in Thai Parkinson's disease patients Journal of the Medical Association of Thailand 90(11): 2277-2283
Barceló, B.; Pérez, C.; Dávila, N.; Lucas, T.; Salto, L.; Alcañiz, J. 1983: Endocrinologic evaluation of 61 patients with acromegaly treated with transsphenoidal removal alone, or associated with telecobalt irradiation or bromocriptine or both Medicina Clinica 80(17): 735-741
Calne, D.B. 2003: Parkinson's disease over the last 100 years Advances in Neurology 91: 1-8
Guillard, A. 1987: Parkinson's disease 20 years later Presse Medicale 16(32): 1565-1566
Slomska, J.; Rattka, P. 1970: Clinical characteristics of patients with Hodgkin's disease treated at the Institute of Oncology at Gliwice in the years 1947-1962 Polski Tygodnik Lekarski 25(32): 1210-1212
Danielczyk, W. 1995: Twenty-five years of amantadine therapy in Parkinson's disease Journal of Neural Transmission. Supplementum 46: 399-405
Kukolewska-Machnicka, J. 1974: Symptomatic zoster in patients with Hodgkin's disease treated at the Radiotherapy Department of the Medical Academy in the years 1960-1971 Polski Przeglad Radiologii i Medycyny Nuklearnej 38(2): 205-210
He, Y.; Yao, J.; Wu, X.; Deng, Y. 1998: Studies on target localization of Parkinson's disease treated with gamma knife Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 15(3): 277-281; 302
Gładysz, A.; Machaj, A.; Simon, K.; Gruszecka, H.; Molin, I.; Lukowiak, J. 1991: Clinical characteristics of patients with AIDS treated at the Infectious Disease Clinic, Medical Academy, in Wrocław during the years 1989-1990 Przeglad Epidemiologiczny 45(4): 365-368
Chen, Y.-L.'; Feng, W.-J.; Zhang, X.-L. 2012: Parkinson's disease combined with overactive bladder syndrome treated with acupuncture and medication Zhongguo Zhen Jiu 32(3): 215-218
Zaccaria, A.; Baccarani, M.; Lauria, F.; Fiacchini, M.; Mazza, P.; Tura, S. 1979: Acute leukemia in patients treated for Hodgkin's disease: report of two cases Haematologica 64(4): 455-462
Nishinaka, T.; Kuroda, S.; Hayashi, Y.; Fujisawa, Y. 1990: Motor neuron disease with Parkinson's disease--case report Rinsho Shinkeigaku 30(11): 1252-1255
Nishiyama, K.; Mizuno, T.; Sakuta, M.; Kurisaki, H. 1993: Chronic dementia in Parkinson's disease treated by anticholinergic agents. Neuropsychological and neuroradiological examination Advances in Neurology 60: 479-483
Jiménez Jiménez, F.J.; Ladero Quesada, J.M. 1990: An experimental model of Parkinson disease caused by a neurotoxin: implications in the clinical aspects and the etiology of Parkinson disease Medicina Clinica 94(15): 585-595